Firm type · Focus area

Pharma Corporate Venture Arms

The RaiseHunt database lists 217 Pharma corporate venture arms: 215 of them list a portfolio, 1,212 known investments between them and 457 people at those firms have a profile here. That is the overlap between 5,455 corporate venture arms and 1,040 Pharma investment firms. Most list Seed and Series A among the rounds they take part in; the largest concentrations are in Shanghai, Tokyo and Cambridge.

Part of corporate venture arms and Pharma investment firms.

Strongest in Shanghai, Tokyo and Cambridge

Backing rounds at Seed and Series A

217
Investment firms
215
With a known portfolio
1,212
Known investments
457
People with a profile

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

217 Pharma corporate venture arms

Showing 61-80

Seoul, South Korea
Corporate VC
AIHealthcare
View fund
Shanghai, China
Corporate VC
Healthcare
View fund
Antwerp, Belgium
Corporate VCPrivate equity
FoodHealthcare
View fund
Shanghai, China
Corporate VC
Healthcare
View fund
Denver, United States
Corporate VC
HealthcareSaaS
View fund
Seoul, South Korea
Corporate VC
AIHealthcare
View fund
Luxembourg
Corporate VCVenture capital
Healthcare
View fund
Basel, Switzerland
Corporate VC
Healthcare
View fund
Corporate VC
Healthcare
View fund
Edmonton, Canada
Corporate VC
ConsumerHealthcare
View fund
Shanghai, China
Corporate VC
Healthcare
View fund
Dongcheng District, China
Corporate VC
ClimateHardware
View fund
Amsterdam, Netherlands
Corporate VCVenture debt
Healthcare
View fund
Corporate VC
Healthcare
View fund
San Diego, United States
Corporate VC
AIHealthcare
View fund
Madrid, Spain
Corporate VC
FinTechHealthcare
View fund
Anantapur, India
Corporate VC
CommerceFood
View fund
Or Akiva, Israel
Corporate VC
Healthcare
View fund
Wilmington, United States
Corporate VC
ClimateFood
View fund
Brisbane City, Australia
Corporate VCPrivate equity
FinTechHardware
View fund

Data: RaiseHunt investor dataset · Snapshot 2 October 2026 · How this data is built · Report a correction or request removal